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CARDIOVASCULAR MEDICINE
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Objective: To determine the diagnostic potential of a hand carried cardiac ultrasound (HCU) device
(OptiGo, Philips Medical Systems) in a cardiology outpatient clinic and to compare the HCU diagnosis
with the clinical diagnosis and diagnosis with a full featured standard echocardiography (SE) system.
Methods: 300 consecutive patients took part in the study. The HCU examination was performed by an
experienced echocardiographer before patients visited the cardiologist. The echocardiographer noted
whether the HCU device was able to confirm or reject the referral diagnosis, which abnormality was
detected, and whether SE investigation was necessary. Physical examination by a cardiologist followed
and thereafter, whenever required, a complete study with an SE was carried out. The HCU data were
compared with the clinical diagnosis of the cardiologist and the SE diagnosis in a blinded manner.
Results: The cardiologist referred 203 of 300 patients for an SE study and 13 patients for
transoesophageal echocardiography. In 84 patients no further examination was considered necessary.
HCU echocardiography was able to confirm or reject the suspected clinical diagnosis in 159 of 203 (78%)
patients. In 44 of 203 (22%) patients SE Doppler was needed. Agreement between the HCU device and the
SE system for the detection of major abnormalities was excellent (98%). The HCU device missed 4% of the
major findings. Among the 84 patients not referred for an SE, the HCU device detected unsuspected major
abnormalities missed with the physical examination in 14 (17%).
Conclusion: Integration of an HCU device with the physical examination augments the yield of information.
T
he physical examination is the cornerstone of the
evaluation of patients referred to the outpatient cardiol-
ogy clinic, but often fails to provide a conclusive
diagnosis. Since the introduction of echocardiography and
Doppler, the limitations of the physical examination of
specific cardiac abnormalities especially in their early stage
have been shown.1 In addition, the auscultation skills and
experience of cardiologists have declined due to less training
in the curriculum as a result of the existing time pressure and
the increasing availability and reliance on more sophisticated
imaging methods.2–5 Consequently, echocardiography and
Doppler are the initial diagnostic tests ordered for most of the
patients. In practice, most of these tests are performed several
days after the first patient–physician encounter, leading to a
delay in the final diagnosis and sometimes treatment.
Recently, small hand carried cardiac ultrasound (HCU)
devices have become available and initial studies have shown
their validity in the immediate diagnosis of cardiac abnorm-
alities at the point of care.6–10 HCU examination may
differentiate normal from abnormal conditions and recognise
patients with significant cardiac abnormalities that can be
missed by physical examination alone.
The aim of the present study was to determine the
diagnostic potential of an HCU device in patients referred
for an initial visit to the outpatient cardiology clinic (new
patients). The HCU diagnosis was compared with the
diagnoses of the cardiologist’s physical examination and of
a full featured standard echocardiography (SE) examination.
MATERIALS AND METHODS
Study population and design
During a five month period, 300 new patients referred to the
outpatient clinic of the Thoraxcentre, Rotterdam, were
examined with an HCU device by an experienced echocardio-
grapher (cardiologist) before the patient’s initial visit to the
cardiologist. Table 1 lists the patients’ characteristics. The
echocardiographer had the referral diagnosis for which the
patient was sent to the cardiologist. She took a brief history,
performed the HCU examination (maximum duration 10
minutes), and noted her findings together with a qualitative
assessment and quantitative results. She then noted whether
further echocardiography and Doppler examination with SE
was needed. Subsequently, the patient was examined by the
consulting cardiologist, who was unaware of the HCU
evaluation and who decided whether an echocardiographic
examination with an SE system (Sonos 5500, Philips Medical
Systems, Eindhoven, the Netherlands; or System Five,
Vingmed, Horten, Norway) was indicated. This examination
was then performed by an independent echocardiographer
(sonographer) who was blinded to the HCU results. A
cardiologist not involved in the study interpreted the SE
examination results. All patients had an ECG recorded as a
routine clinical practice. The clinical diagnosis made by the
physician was based on the combination of clinical history,
physical examination, and ECG findings. The institutional
medical ethics committee approved the study and informed
consent was obtained from all patients.
The HCU device
The OptiGo (Philips Medical Systems) HCU device was used
(fig 1). It is equipped with a 2.5 MHz phased array broad-
band transducer and operates on a rechargeable lithium ion
battery or alternating current. Two dimensional imaging,
colour flow Doppler imaging, and two callipers for linear
measurements are also integrated with the system. Images
are documented on a CompactFlash card.
Abbreviations: HCU, hand carried cardiac ultrasound; LV, left
ventricular; SE, standard echocardiography
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Echocardiographic diagnosis with the HCU device
Cardiovascular abnormalities were classified as major or
minor. Major abnormalities were considered to be the
clinically significant abnormalities that would trigger further
diagnostic evaluation, to change or initiate treatment
management, or to have prognostic significance (table 2).
Minor abnormalities were considered to be abnormalities
that were of no clinical significance and would therefore not
affect decision making for patient management.
Valve or flow abnormalities detected with the HCU device
were evaluated with the pulsed and continuous wave Doppler
modalities of the SE. The severity of these abnormalities was
graded according to standard methods.11
Unsuspected major abnormalities (see table 2 for definition
of ‘‘major’’) were considered to be the echocardiographically
detected major abnormalities that were not reported in the
history or were not suspected or previously described from
the symptoms of the patient. Furthermore, the cardiologist’s
physical examination missed these abnormalities.
Statistical analysis
Descriptive statistics are reported as mean (SD) for contin-
uous variables and as percentages for categorical variables.
The agreement between the two examination techniques for
the detection of major abnormalities was assessed from 26 2
tables with weighted k statistics. On the basis of Fleiss’s
classification, k values , 0.4, between 0.4 and 0.75, and
. 0.75 were considered to indicate poor, fair to good, and
excellent agreement, respectively.12
RESULTS
General results
Table 3 presents the most common referral question or
suspected diagnosis for the 300 patients sent by the primary
care physician to the cardiology outpatient clinic. The
cardiologist requested after his physical examination an
echocardiographic examination for 203 of the 300 (68%)
patients. Table 3 also lists the most common referral question
or suspected clinical diagnosis for which the SE was
requested in these 203 patients. Thirteen of 300 (4%) patients
were sent for a transoesophageal study for the evaluation of a
cardiac source of embolism. No further examination was
considered necessary for 84 of the 300 (28%) patients.
Patients sent for an SE by the cardiologist
The HCU examination was able to confirm or reject the
clinical diagnosis of the cardiologist in 159 of the 203 (78%)
patients. For example, a suspected clinical diagnosis of left
ventricular (LV) hypertrophy can be easily and reliably
confirmed or rejected with an HCU examination without
the need for SE.8
In 44 of 203 (22%) patients the HCU device was able to
confirm or reject the clinical diagnosis, but haemodynamic
Doppler assessment was regarded as necessary. Since this
feature was not available on the HCU an SE examination
followed for the evaluation of the following findings: severity
of valve stenosis (14 patients); valvar regurgitant lesion (10
patients); diastolic LV function (four patients); LV outflow
tract obstruction (seven patients); congenital abnormality
(six patients); and prosthetic valve evaluation (three
patients). Of note, in all of these patients the valvar or
congenital lesion was detected and a gross estimation of their
severity was possible with the HCU device.
Patients not sent for SE by the cardiologist
The cardiologist did not refer 84 of 300 (28%) patients for an
SE study. In 17% (14 of 84) of these patients, a major
unsuspected abnormality missed by the physical examination
was detected with the HCU device. Furthermore, the HCU
device detected no abnormalities in 17% (14 of 84) and minor
abnormalities in 66% (56 of 84).
The HCU echocardiographer noted that an SE examination
would be necessary for 14% (12 of 84) of this group of
patients because the Doppler modality was needed (three
patients were from the group with unsuspected major
abnormalities).
Table 1 Baseline characteristics of 300 new
patients referred to the outpatient cardiology
clinic
Characteristic n (%) or mean (SD)
Age (years) 53 (16)
Men 57 (19%)
Documented CAD 61 (20%)
Known hypertension 86 (29%)
Treated DM 11 (4%)
Previous valve repair 4 (1%)
Previous prosthetic valve 3 (1%)
CAD, coronary artery disease; DM, diabetes mellitus.
Figure 1 The OptiGo device, the hand carried cardiac ultrasound
(HCU) device used in the study.
Table 2 Major cardiovascular findings
Finding
Grade constituting major
abnormality
Valve regurgitation . Mild
Valve stenosis Any
LV dysfunction LVEF ,45%
RV dysfunction* Any
LV hypertrophy .14 mm
Mitral valve prolapse Any
Congenital abnormality Any
Pericardial effusion Any
Vegetation Any
Mass lesion Any
*Normal right ventricular (RV) systolic function was defined by normal RV
dimensions (end diastolic transverse diameter (45 mm) in the four
chamber view11; left ventricular (LV) hypertrophy was defined as a
major abnormality when the septal wall thickness was .14 mm.
LVEF, left ventricular ejection fraction.
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Major and minor abnormalit ies detected with the HCU
device and the SE system
In total 217 patients had an SE examination. The cardiologist
referred 203 patients and the HCU examiner independently
referred 14 patients.
The agreement between the two devices for the detection
of major abnormalities was excellent (98%, k = 0.95)
(table 4). Table 5 lists the abnormalities detected by the SE
system and missed by the HCU device and the physical
examination. The HCU device missed six major abnormal-
ities: a small ventricular septal defect that was located high,
two aortic stenosis (one moderate with a peak gradient of
40 mm Hg and one mild with a peak gradient of 25 mm Hg),
a moderate mitral and aortic regurgitation, both in the same
patient with a poor echo window, and a moderate LV
dysfunction.
Figure 2 gives a simple overview of the correlation of major
and minor findings between the HCU device and the SE
system.
Unsuspected major findings
In total, 71 unsuspected major findings were detected
echocardiographically in 61 of 300 patients (20%).
Importantly, of these 71 findings 15 were present in 14 of
the 84 (17%) patients not referred to SE by the cardiologist.
In particular, these findings were LV hypertrophy (six
patients), hypertrophic obstructive cardiomyopathy (one
patient), LV dysfunction or wall motion abnormalities (three
patients), valvar regurgitation (two patients), dilated ascend-
ing aorta (one patient), mitral valve prolapse (one patients),
and pericardial effusion (one patient). Two of these findings
were detected in the same patient. Three patients needed SE
Doppler examination for gradient evaluation after the HCU
examination. Physical examination misdiagnosed hyper-
trophic obstructive cardiomyopathy as aortic stenosis in one
patient.
The 71 unsuspected major findings were the following: LV
hypertrophy (28 patients), valvar regurgitation (20 patients),
valvar stenosis (six patients), LV dysfunction (five patients),
hypertrophic cardiomyopathy (four patients), and miscella-
neous (eight patients).
Figures 3, 4, and 5 present examples of major unsuspected
findings detected with the HCU device and verified with the
SE system.
DISCUSSION
The first HCU device to augment the physical examination
was introduced by Roelandt and colleagues in Rotterdam in
1978.13–15 However, the combination of the poor image
quality, technical limitations, and reimbursement issues
discontinued its development. Today, advances in micro-
processor technology have led to a new generation of portable
echocardiographic systems with excellent image quality and
significantly lower cost than SE machines. Several studies
have shown their efficacy and accuracy for the diagnosis of
major abnormalities at the point of care.6 10 16
Table 3 Reasons for referral by primary care physicians
and cardiologists
Possible diagnosis/question Proportion
Referral to outpatient cardiology clinic by primary
care physician (300 patients)
LV dysfunction 31%
Preoperative cardiac evaluation 15%
Rhythm abnormalities 14%
Cardiac source of embolism 8%
Family history 7%
LV hypertrophy 5%
Murmur evaluation 5%
Dyspnoea, fatigue, dizziness 4%
Congenital abnormality 4%
Miscellaneous 6%
Referral to the echocardiographic laboratory by
the cardiologist (203 patients)
LV dysfunction 59%
Valve evaluation 27%
LV hypertrophy 11%
Congenital abnormality 7%
Mitral valve prolapse 4%
Prosthetic valve evaluation 2%
Endocarditis 2%
RV dysfunction 1.5%
Thrombus 1%
The preoperative patient group had either symptoms or a history of
cardiac disease.
Table 4 Agreement of detection of major abnormalities
in 217 patients between the OptiGo and a standard
echocardiography system
SE system
Abnormal Normal
HCU device Abnormal 92 0
Normal 5 120
Data are the absolute number of patients.
Agreement 98%, k =0.95, sensitivity 95% (95% confidence interval (CI)
0.91 to 0.91)), specificity 100% (95% CI 0.97 to 0.97), positive predictive
value 100% (95% CI 0.96 to 0.96), negative predictive value 96%
(95% CI 0.93 to 0.93).
HCU, hand carried cardiac ultrasound; normal, no abnormalities or
minor abnormalities; SE, standard echocardiography.
Table 5 Comparison between the SE system and the
HCU device in the detection of minor and major
cardiovascular findings in 203 patients sent for an SE
examination
Finding
SE: finding
detected
HCU
device:
finding
missed
Physical
exam:
finding
missed
Minor findings NA
Aortic regurgitation 31 7 NA
Mitral regurgitation 70 13 NA
Tricuspid regurgitation 49 18 NA
Total 150* 38 NA
Major finding
Aortic stenosis 14 2 4
Aortic regurgitation 10 1 5
Mitral stenosis 3 0 2
Mitral regurgitation 18 1 7
Tricuspid regurgitation 6 0 5
Pulmonary stenosis 1 0 0
LV systolic dysfunction 34 1 2
RV systolic dysfunction 1 0 0
LV hypertrophy 29 0 23
Mitral prolapse 5 0 3
Ventricular septal defect 4 1 1
Atrial septal defect 3 0 0
Pericardial effusion 3 0 1
HOCM 7 0 3
Total 138 6 56
Some patients had more than one cardiovascular abnormality.
*The 150 minor findings were present in 107 patients; the 138 major
findings were present in 83 patients. The physical examination missed 56
major findings (in 47 patients). Physical examination misdiagnosed
moderate mitral regurgitation as aortic stenosis (false positive) in two
patients and aortic stenosis as mitral regurgitation in one patient.
HOCM, hypertrophic obstructive cardiomyopathy; NA, not applicable.
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In the current study in 78% of patients sent for a full
featured SE examination by the cardiologist, the HCU device
provided instant information potentially sufficient to avoid
an SE examination. Compared with the SE system, the HCU
device had a positive predictive value in diagnosing the major
abnormalities of 100% and a negative predictive value of 96%.
Furthermore, an unsuspected major abnormality was found
in 23% of these patients with both the HCU device and the SE
system. These abnormalities were not expected based on the
history and the patient’s symptoms and were on top of the
clinical referral diagnosis made by the cardiologist. The HCU
device missed 4% of the major findings. However, it is
obvious that knowing the results of the physical examination
and the detailed clinical history beforehand would have led
to a more focused echocardiographic examination for major
findings with high probability and would have reduced the
number of missed findings by the HCU device.
Most important, in 84 of 300 (28%) patients the
cardiologist considered his physical examination sufficiently
accurate to decide that echocardiographic assessment was
unnecessary. However, in 17% of these patients unsuspected
major abnormalities were found with the HCU device and
missed by the physical examination. This is in concordance
with the study of Fedson and colleagues.17 It is obvious that
direct visualisation leads to a more accurate diagnosis than
indirect observation by palpation and auscultation even by
the best experts. ‘‘Seeing’’ enables the pre-symptomatic
detection of abnormalities and of abnormalities that are
beyond physical signs. It is generally recognised that physical
examination has shortcomings and that the clinical diagnosis
Figure 2 Agreement between the hand carried cardiac ultrasound (HCU) device and standard echocardiography (SE) system was 98% (k = 0.95).
HCU found unexpected major abnormalities in 14 of 84 (17%) patients. *Absolute number of patients with abnormalities; findings from the
transoesophageal echocardiography (TOE) examination; `of the 84 patients not referred for echocardiography by the cardiologist, 14 with major
abnormalities on the HCU underwent SE examination after it was requested by the HCU echocardiographer.
Figure 3 Parasternal long axis view of a 48 year old patient with a
dilated ascending aorta (42 mm). The patient had a history of
palpitations and was referred to the outpatient cardiology clinic for
evaluation of atrioventricular nodal re-entry tachycardias.
Figure 4 Parasternal long axis view of a 46 year old woman with a
history of cancer. She was referred for preoperative evaluation. Left
ventricular end diastolic dimension is 69 mm. Ejection fraction was
visually estimated to be, 35%. The patient has dilated cardiomyopathy.
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of many common cardiac conditions such as pericardial
effusion, early LV dysfunction, hypertrophic cardiomyopathy,
or silent valvar disease can challenge the most experienced
clinicians, whereas they are readily diagnosed by echocardio-
graphy and Doppler examination.1 18 The incorporation of
HCU into the physical examination can undoubtedly provide
physicians with instant valuable information assisting them
in clinical diagnosis and patient management. In the current
study the HCU device was tested in an outpatient cardiology
clinic. The HCU device has been studied in various clinical
settings.6 10 19 20
Patients referred to our outpatient clinic, which is a tertiary
referral centre, have a high prevalence of cardiac disease,
which explains the high number of requests for an
echocardiographic examination. However, since outpatient
echocardiographic examinations are often performed several
days after the patient’s first visit, the patient must return to
the hospital for the examination. With the incorporation of
HCU into the physical examination, this extra visit to the
hospital could have been avoided by 78% of our study cohort
for whom the cardiologist requested an SE examination. But
even for the institutions where an SE examination is
standard procedure after the physical examination, the
integration of HCU with the physical examination can lead
to significant cost and time savings, since the majority of
referred patients have no abnormalities.
Our study is in concordance with the study of Spencer and
colleagues,21 who compared HCU echocardiography at the
point of care with the physical examination in a smaller
patient cohort (36 patients). They reported that the use of
this device by cardiologists reduced the number of major
cardiovascular findings missed by the clinical examination.
Minor abnormalities were more easily missed. This is in
agreement with our findings that the HCU device detected
mild valvar regurgitations in only 112 of 150 patients.
Furthermore, Galasko and colleagues19 studied 562 patients
in a community setting with the same HCU device and
correctly identified major abnormalities (LV dysfunction, LV
hypertrophy, and left sided valvar regurgitation). They also
concluded that minor disease is more likely to be missed.
Spectral flow Doppler is available on some of the HCU
devices. Such devices have been shown to overcome
limitations in evaluating haemodynamic variables22 and
may limit referral for the full featured SE system even
further. But still this needs to be evaluated in further studies.
Training requirements
There is no doubt that training is required to use an imaging
device. The current study was performed by a cardiologist
with expertise in both echocardiography and HCU devices
(ECV). Training of clinicians and non-echocardiographers
should focus on the criteria of identifying a normal heart and
diagnosing major and acute cardiac disorders. The American
Society of Cardiology23 has recently published guidelines
regarding the use of such devices, recommending level I
training as an absolute minimum.24 However, recent studies
have suggested that it is possible to train physicians and
students to detect significant structural or flow abnormalities
in a short period of time with high efficacy.25–29
Physical examination remains the cornerstone of cardio-
vascular assessment and its use should be encouraged.
However, visualising the heart at the point of care helps us
to differentiate normal from abnormal conditions and thus to
reduce the number of normal referrals, leading to targeted
referrals for further diagnostic assessment whenever
regarded as necessary. The HCU device should be used as
phonocardiography was used in the past: whenever docu-
mentation was needed after auscultation. Thus, in case of
doubt or whenever haemodynamic and quantitative informa-
tion is crucial for further management, an examination with
a full featured SE system should follow the HCU examina-
tion. The appropriate training of clinicians to use such devices
is the basic element needed for the future use of the HCU
device in daily clinical practice and efforts should be made in
this respect.
It should be remembered that the real value of any imaging
technology is intimately dependent on our intellectual
contribution and individual responsibility.
Limitations
The HCU device that was used for this study had no spectral
Doppler modality to obtain haemodynamic data. The valvar
abnormalities were evaluated qualitatively with the two
dimensional and colour flow Doppler features. However,
continuous wave and pulsed wave Doppler echocardiography
is necessary for an accurate assessment of valvar regurgita-
tion or stenosis. Furthermore, examination of transmitral
flow gives information about the diastolic function and filling
pressures. Since this was a blind study, the cardiologist was
not aware of which patients had undergone an HCU
examination. This was done to avoid any bias that would
lead the cardiologist to change his potential request for an
SE. Therefore, not all patients had an SE examination, but
only when the cardiologist requested it. However, many
studies have already proved the accuracy and reliability of the
HCU device compared with the SE system in detecting
cardiovascular abnormalities. Furthermore, the main interest
is to compare the yield of the physical examination with
versus without an HCU device.
Figure 5 Apical four chamber view of a 45 year old patient with
(A) prolapse of the posterior mitral leaflet and (B) an eccentric jet
towards the interatrial septum. The patient was referred for evaluation of
palpitations and was known to have a systolic murmur.
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Conclusion
In patients who attend the outpatient cardiology clinic,
integration of an HCU device with the physical examination
allows the immediate detection of structural cardiac disease.
Often a definitive diagnosis is made or the patient is referred
for specific diagnostic tests. A major advantage is that
patients with no cardiac abnormality can avoid further
echocardiographic tests (negative predictive value is 96%).
It appears that the yield of the physical examination is
augmented, which alone may miss significant abnormalities.
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Heart Online case reports: www.heartjnl.com
T
he follow electronic only articles are published in
conjunction with this issue of Heart.
Subacute coronary stent thrombosis in a patient
developing clopidogrel associated thrombotic
thrombocytopenic purpura
M-A von Mach, A Eich, L S Weilemann, T Mu¨nzel
Clopidogrel, in combination with aspirin, is commonly used
for the prevention of thrombosis in patients who have
received coronary artery stents. As a rare but critical
complication, clopidogrel associated thrombotic thrombo-
cytopenic purpura (TTP) has previously been described. A 78
year old man presented with unstable angina and filiform
subtotal stenosis of the left anterior descending artery. He
was treated with balloon angioplasty and stent implantation.
After four days the patient again had angina caused by stent
thrombosis, which was treated with balloon angioplasty.
During hospital stay the typical course of clopidogrel
associated TTP was observed with thrombocytopenia and
petechial purpura occurring 14 days after drug initiation and
prompt response to therapeutic plasma exchanges. These
findings strongly suggest that clopidogrel may have increased
platelet activation and aggregation in this immunologically
susceptible patient, ultimately leading to a stent thrombosis.
(Heart 2005;91:e14) www.heartjnl.com/cgi/content/full/91/
2/e14
Delayed severe multivessel spasm and aborted
sudden death after Taxus stent implantation
J W Kim, C G Park, H S Seo, D J Oh
Sudden cardiac arrest associated with major spasm of three
coronary arteries was observed about 10 hours after Taxus
stent insertion in a three vessel lesion and was successfully
treated by intracoronary glyceryl trinitrate infusion. This case
illustrates a potential risk associated with drug eluting stent
and alerts clinicians to the life threatening risk of spasm
when stenting multiple vessels with drug eluting stent
(especially the Taxus stent).
(Heart 2005;91:e15) www.heartjnl.com/cgi/content/full/91/
2/e15
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